Royalty Reports Sample Clauses

The Royalty Reports clause requires a party, typically a licensee, to provide regular, detailed statements outlining the royalties owed to the other party, usually the licensor. These reports often include information such as sales figures, units sold, or revenue generated from the licensed product or service, and are submitted on a set schedule, such as quarterly or annually. By mandating transparent and timely reporting, this clause ensures accurate royalty payments and helps prevent disputes over underpayment or misreporting.
POPULAR SAMPLE Copied 4 times
Royalty Reports. 4.6.1 Within *** (***) days after the end of the first, second and third calendar quarters of each calendar year and within *** (***) days after the end of the fourth quarter during each calendar year, commencing with the calendar quarter in which there is a first commercial sale of a Product, to the extent such information is reasonably available, ViroPharma shall furnish to Halozyme a written report showing in reasonably specific detail, on a country-by-country basis, (a) the quantity, average sales price and aggregate gross sales of all Products sold by ViroPharma, its sublicensees and their respective Affiliates during such calendar quarter and the calculation of Net Sales from such gross sales; (b) the calculation of the royalties, if any, which shall have accrued based upon such Net Sales; (c) the withholding taxes, if any, required by law to be deducted with respect to such sales; and (d) the exchange rates, if any, used in determining the amount of United States dollars. 4.6.2 With respect to sales of Products invoiced in United States dollars, all such amounts shall be expressed in United States dollars. With respect to sales of Products invoiced in a currency other than United States dollars, all such amounts shall be expressed both in the currency in which the sale is invoiced and in the United States dollar equivalent. The United States dollar equivalent shall be calculated using the average of the exchange rates (local currency per US$1) published in The Wall Street Journal, Western Edition, under the heading “Currency Trading” on the last business day of each month in the applicable calendar quarter. All royalties payable hereunder shall be calculated based on Net Sales expressed in United States dollars. 4.6.3 ViroPharma shall keep, to the extent such information is reasonably available, complete and accurate records in sufficient detail to properly reflect all gross sales and Net Sales and to enable the royalties payable to be determined. 4.6.4 All royalties shown to have accrued by each royalty report provided under this Section 4.6 shall be payable on the date such royalty report is due. Payment of royalties in whole or in part may be made in advance of such due date.
Royalty Reports. After the first SALE anywhere in the world, LICENSEE will make quarterly royalty reports to REGENTS within sixty (60) days after the quarters ending March 31, June 30, September 30, and December 31, of each year. If no SALEs have occurred during the report period, a statement to this effect is required in the royalty report for that period. Each such royalty report will be substantially similar to APPENDIX A and include at least the following: (a) The number of LICENSED PRODUCTS manufactured and the number SOLD; (b) Gross revenue from SALE of LICENSED PRODUCTS, LICENSED SERVICES and LICENSED METHODS; (c) NET SALES pursuant to Paragraph 2.8; (d) Total royalties due REGENTS; and (e) Names and addresses of any new SUBLICENSEES along with a summary of the material terms of each new SUBLICENSE entered into during the reporting quarter.
Royalty Reports. Within sixty (60) days after the end of each calendar quarter during the term of this Agreement following first to occur of the First Commercial Sale of a Product and the receipt by Oxis or its Affiliates of Net Sublicensing Revenues, Oxis shall furnish to Licensor a quarterly written report showing in reasonably specific detail (a) the calculation of Net Sales during such calendar quarter; (b) the calculation of Net Sublicensing Revenues for such quarter; (c) the calculation of the royalties, if any, that shall have accrued based upon such Net Sales and Net Sublicensing Revenues; (d) the withholding taxes, if any, required by law to be deducted with respect to such sales; and (e) the exchange rates, if any, used in determining the amount of United States dollars. With respect to sales of Products invoiced in United States dollars, the gross sales, Net Sales and royalties payable shall be expressed in United States dollars. With respect to (i) Net Sales invoiced in a currency other than United States dollars and (ii) cash consideration paid in a currency other than United States dollars by Oxis's sublicensees hereunder, all such amounts shall be expressed both in the currency in which the distribution is invoiced and in the United States dollar equivalent. The United States dollar equivalent shall be calculated using the average of the exchange rate (local currency per US$1) published in The Wall Street Journal, Western Edition, under the heading "Currency Trading" on the last business day of each month during the applicable calendar quarter.
Royalty Reports. After the first commercial sale of a Licensed Product anywhere in the world, LICENSEE shall submit to UNIVERSITY [***] royalty reports on or before [***] of each year. Each royalty report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar year and shall show: (i) the date of first commercial sale of a Licensed Product in each country; (ii) the gross sales, deductions as provided in Paragraph 1.4 (Net Sales), and Net Sales during the most recently completed calendar year and the royalties, in US dollars, payable with respect thereto; (iii) the number of each type of Licensed Product sold; (iv) Sublicense fees and royalties received during the most recently completed calendar year in US dollars, payable with respect thereto; (v) the method used to calculate the royalties; and (vi) the exchange rates used. If no sales of Licensed Products have been made and no Sublicense revenue has been received by LICENSEE during any reporting period, LICENSEE shall so report. The reports referred to in this Paragraph 4.1(b) should be marked with the following title and case number: “License Agreement between UC SAN DIEGO and Oxitope, Inc. for case SD2005-037.” Reports shall be submitted as an attachment to UC SAN DIEGO’s email address: ▇▇▇-▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇.
Royalty Reports. Licensee shall submit to Cornell a Royalty Report annually on or before October 1st for the sales of Licensed Variety during the prior 12 month period beginning October 1st and ending on September 30th of that year. Licensee may use the Royalty Report provided in Exhibit A.
Royalty Reports. After the first commercial sale of a Licensed Product anywhere in the world, LICENSEE shall submit to UNIVERSITY quarterly royalty reports on or before each February 28, May 31, August 31 and November 30 of each year. Each royalty report shall cover LICENSEE's (and each Affiliate's and Sublicensee's) most recently completed calendar quarter and shall show: (1) the gross sales, deductions as provided in Paragraph 1.11, and Net Sales during the most recently completed calendar quarter and the royalties, in US dollars, payable with respect thereto; (2) the number of each type of Licensed Product sold; (3) sublicense fees and royalties received during the most recently completed calendar quarter in US dollars, payable with respect thereto; (4) the method used to calculate the royalties; and (5) the exchange rates used. If no sales of Licensed Products has been made and no sublicense revenues has been received by LICENSEE during any reporting period, LICENSEE shall so report.
Royalty Reports. (a) Commencing on the 25th day of May, 2001 and on the 25th day of July, November and February thereafter during the Term (i) Licensee shall, and shall contractually require all sublicensees to, furnish to Licensor, with respect to the three-month period immediately prior to the date of the statement, and for the 12-month period or portion thereof in question, on a cumulative basis, a written statement (certified by the Chief Financial Officer of Licensee or such sublicensee), in such form and with such detail as Licensor may reasonably require, setting forth (i) the Handle, Hold, Gross Profit generated during such quarter, as a result of the use of the System and/or and the Licensed Technology, or any part thereof, (ii) the calculation of, and method of calculating, the Percentage Fees and (iii) such other information relating to the computation of the fees owed to Licensor under this Agreement as Licensor may reasonably request from time to time. All such statements shall to the extent practicable be generated directly by the System or using the Licensed Software. (b) Licensee shall, and shall contractually require all of its sublicensees to, keep accurate written records of all activities relating to the Handle, Hold, Gross Profit and calculation of the Percentage Fees. Such records shall be retained by Licensee or its sublicensees during the Term and for a period of at least two (2) years thereafter. Upon reasonable notice and during regular business hours, Licensee shall, and it shall contractually require its sublicensees to, make available such records for audit by Licensor or its representatives to verify the accuracy of the statements provided to Licensor; provided that any audit of a sublicensee shall be conducted through the Licensee, all communications with such sublicensee shall be exclusively through the Licensee and Licensor shall have no direct communication with any such sublicensee unless Licensee fails to fulfill the requirements of Section 3.7(f). In the event it is determined that the fees paid to Licensor hereunder were less than the fees to which Licensor was entitled as provided herein, Licensee shall immediately pay such fees plus interest as provided in Section 5.9, and Licensee shall pay all reasonable, out-of-pocket expenses of Licensor or its representatives relating to such audit, including, but not limited to the reasonable, out-of-pocket expenses of traveling to Licensee's or its sublicensees' facilities or otherwise, and re...
Royalty Reports. At the end of the Initial Term, and at the end of any Renewal Period agreed to by the Parties, Licensee shall provide University a report indicating the total sales amounts of Licensed Articles, total units of Licensed Articles sold, and the specific location where such sales were made.
Royalty Reports. LICENSEE shall provide a sales report to SYSTEM each BUSINESS YEAR, providing information sufficient to allow SYSTEM to calculate amounts due to SYSTEM for the reporting period, in the form attached hereto as ANNEX II.
Royalty Reports. Within [**] days after the end of each Quarter following the first Sale, Company will deliver to Penn a report, certified by the chief financial officer of Company, detailing the calculation of all royalties, fees and other payments due to Penn for such Quarter. The report will include, at a minimum, the following information for the Quarter, each listed by product, by country: (a) the number of units of Licensed Products or Other Licensed Products, as the case may be, constituting Sales; (b) the gross consideration received for Sales; (c) Qualifying Costs, listed by category of cost; (d) Net Sales; (e) the gross amount of any payments and other consideration received by Company from sublicensees and the amounts of any deductions permitted by Section 3.6; (f) the royalties, fees and other payments owed to Penn, listed by category; and (g) the computations for any applicable currency conversions. Each royalty report will be substantially in the form of the sample report attached as Exhibit D.